跳至主要内容
临床试验/NCT05684562
NCT05684562招募中不适用

Pulmonary Determinants of Cardiorespiratory Fitness in Patients With Fontan Procedure

Hacettepe University2 个研究点 分布在 2 个国家目标入组 78 人开始时间: 2023年12月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
78
试验地点
2
主要终点
FEV1/FVC

研究概览

简要总结

This study will examine and record the patient's medical information and medical records (patient files, computer records, etc.). Physical examination, echocardiographic, electrocardiographic, laboratory, radiological, etc. evaluations are made during the routine controls of the patients. Within the scope of this study, no attempt will be made on the patients, no additional tests will be performed, or treatment changes will not be made in the patients because they are included in this study. After these records, KPET will be performed by a specialist doctor and physiotherapist for the patients who are directed to the Faculty of Physical Therapy and Rehabilitation Cardiopulmonary Rehabilitation Unit. Pulmonary function tests and respiratory muscle strength measurements will be performed on patients who have adequate rest after CPET.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
8 Years 至 55 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Fontan Group Inclusion Criteria:
  • Be between 8-55 years old
  • Having undergone a Fontan operation
  • Clinical stability of the patients (preserved ventricular function)
  • No change in ongoing drug therapy that adversely affects clinical stability
  • At least 1 year after the operation
  • Fontan Group

排除标准

  • Neurological and/or genetic musculoskeletal disease
  • Having orthopedic and cognitive problems that prevent testing
  • The patient's and/or family's unwillingness to participate in the study
  • Control Group Inclusion Criteria:
  • Not have cardiovascular, neurological, and/or genetic musculoskeletal disease
  • Not having orthopedic and cognitive problems that prevent testing
  • The patient's and/or family's willingness to participate in the study

研究组 & 干预措施

Fontan group

Cardiopulmonary exercise test Pulmonary function test respiratory muscle strength test

干预措施: Cardiopulmonary exercise test (Other)

Fontan group

Cardiopulmonary exercise test Pulmonary function test respiratory muscle strength test

干预措施: Pulmonary function test (Other)

Fontan group

Cardiopulmonary exercise test Pulmonary function test respiratory muscle strength test

干预措施: Respiratory muscle strength test (Other)

Control Group

Cardiopulmonary exercise test Pulmonary function test respiratory muscle strength test

干预措施: Cardiopulmonary exercise test (Other)

Control Group

Cardiopulmonary exercise test Pulmonary function test respiratory muscle strength test

干预措施: Pulmonary function test (Other)

Control Group

Cardiopulmonary exercise test Pulmonary function test respiratory muscle strength test

干预措施: Respiratory muscle strength test (Other)

结局指标

主要结局

FEV1/FVC

时间窗: 15-20 minutes

Maximal inspiratory pressure

时间窗: 15-20 minutes

Ratio curve of minute ventilation to carbon dioxide production (VE/VCO2) slope

时间窗: 30-45 minutes

Ratio of minute ventilation to carbon dioxide production (VE/VCO2)

时间窗: 30-45 minutes

Oxygen uptake efficiency slope (OUES)

时间窗: 30-45 minutes

Maximal oxygen consumption

时间窗: 30-45 minutes

Forced vital capacity (FVC)

时间窗: 15-20 minutes

Forced expiratory volume in 1 second (FEV1)

时间窗: 15-20 minutes

Maximal expiratory pressure

时间窗: 15-20 minutes

Minute ventilation (VE)

时间窗: 30-45 minutes

End tidal carbon dioxide pressure (PetCO2)

时间窗: 30-45 minutes

End tidal oxygen pressure (PetO2)

时间窗: 30-45 minutes

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Haluk TEKERLEK

Research assistant

Hacettepe University

研究点 (2)

Loading locations...

相似试验

已完成
不适用
Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)Lung Disease, Chronic ObstructiveLung Disease, InterstitialHypertension, PulmonarySarcoidosisAsthma
NCT01361139Echosense Ltd.500
Unknown
不适用
Postoperative Respiratory AbnormalitiesRespiratory ArrestRespiratory Distress SyndromeAcute Respiratory Failure With HypoxiaAcute Respiratory Failure With HypercapniaAcute Respiratory Failure Post SurgicalAcute Respiratory Failure PostproceduralAcute Respiratory Failure Following Trauma and SurgeryAcute Respiratory Failure Requiring ReintubationAcute Respiratory Failure Post TraumaticRespiratory FailureAcute Respiratory DecompensationShockShock, SepticShock, CardiogenicAcute Cardiac FailureMulti Organ FailureAcute Kidney FailureAcute Respiratory Failure
NCT04079829Efficacy Care R&D Ltd50,000
已完成
不适用
CPET and Outcome After Oesophagogastric Cancer SurgeryUpper Gastrointestinal Disorders
NCT03637647University Hospital Southampton NHS Foundation Trust611
已完成
不适用
A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat InhalerPulmonary Disease, Chronic Obstructive
NCT02172560Boehringer Ingelheim441
已完成
不适用
Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In ChildrenCorona Virus InfectionPediatric CancerAdult ChildrenCancer
NCT04371315St. Jude Children's Research Hospital33